Eli Lilly Confirms 'Superior Weight Loss' Of Its Next-Generation Obesity Drug
Eli Lilly reported study results Thursday that confirmed the "superior weight loss profile" of its next-gen obesity drug, retatrutide.
Investor's Business Daily
via Investor's Business Daily
Updated 1h ago
Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Deadly meningitis outbreak prompts college students to call for campus shutdown
Next
82 Wisconsin (Mar 19, 2026) Game Recap
Related Articles
BusinessArizona Attorney General Challenges Utility Rate Mechanism for UNS Gas
Myheraldreview-13h ago-1 sources
BusinessStill haven't booked Easter? These 3 Aussie cities have bargain beds for $200 a night
Armidale Express-13h ago-2 sources
BusinessTaking Shape: Downtown Glendive tourism hub closer to reality as designs are finalized
Bozeman Daily Chronicle-13h ago-1 sources